FI118083B - Uusi menetelmä biologisesti aktiivisen dimeerisen proteiinin valmistamiseksi - Google Patents

Uusi menetelmä biologisesti aktiivisen dimeerisen proteiinin valmistamiseksi Download PDF

Info

Publication number
FI118083B
FI118083B FI970229A FI970229A FI118083B FI 118083 B FI118083 B FI 118083B FI 970229 A FI970229 A FI 970229A FI 970229 A FI970229 A FI 970229A FI 118083 B FI118083 B FI 118083B
Authority
FI
Finland
Prior art keywords
tgf
leu
concentration
cys
ser
Prior art date
Application number
FI970229A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970229A0 (fi
FI970229A (fi
Inventor
Nico Cerletti
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI970229A0 publication Critical patent/FI970229A0/fi
Publication of FI970229A publication Critical patent/FI970229A/fi
Application granted granted Critical
Publication of FI118083B publication Critical patent/FI118083B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI970229A 1994-07-25 1997-01-20 Uusi menetelmä biologisesti aktiivisen dimeerisen proteiinin valmistamiseksi FI118083B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP94810438 1994-07-25
EP94810438 1994-07-25
PCT/EP1995/002718 WO1996003432A1 (fr) 1994-07-25 1995-07-12 Nouveaux procedes de production d'une proteine dimere biologiquement active
EP9502718 1995-07-12

Publications (3)

Publication Number Publication Date
FI970229A0 FI970229A0 (fi) 1997-01-20
FI970229A FI970229A (fi) 1997-01-20
FI118083B true FI118083B (fi) 2007-06-29

Family

ID=8218292

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970229A FI118083B (fi) 1994-07-25 1997-01-20 Uusi menetelmä biologisesti aktiivisen dimeerisen proteiinin valmistamiseksi

Country Status (19)

Country Link
US (1) US6057430A (fr)
EP (1) EP0775159B1 (fr)
JP (2) JP3923516B2 (fr)
KR (1) KR100432839B1 (fr)
AT (1) ATE207933T1 (fr)
AU (1) AU690311B2 (fr)
CA (1) CA2194582C (fr)
DE (1) DE69523605T2 (fr)
DK (1) DK0775159T3 (fr)
ES (1) ES2166401T3 (fr)
FI (1) FI118083B (fr)
HU (1) HU222830B1 (fr)
IL (1) IL114701A (fr)
NO (1) NO316926B1 (fr)
NZ (1) NZ290373A (fr)
PT (1) PT775159E (fr)
TW (1) TW440566B (fr)
WO (1) WO1996003432A1 (fr)
ZA (1) ZA956138B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW517059B (en) * 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
WO1997023638A1 (fr) * 1995-12-21 1997-07-03 Ajinomoto Co., Inc. Procede pour replier l'activine a humaine
DE19906096A1 (de) 1999-02-13 2000-08-17 Walter Sebald Protein mit einem Heparin-bindenden Epitop
EP1273655A4 (fr) * 2000-03-30 2004-08-04 Takeda Chemical Industries Ltd Procede de production de proteine de recombinaison
WO2001072331A1 (fr) * 2000-03-31 2001-10-04 Vaccine Chip Technology Aps Proprietes immunostimulantes d'un fragment de tgf-beta
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
GB0514262D0 (en) * 2005-07-12 2005-08-17 Renovo Ltd Promotion of epithelial regeneration
GB0604938D0 (en) * 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
GB0617816D0 (en) * 2006-09-11 2006-10-18 Renovo Ltd Nucleic acids and methods of protein expression
US8986769B2 (en) 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
CN110382523B (zh) 2016-12-30 2024-04-16 博晟生医股份有限公司 重组多肽及其组合物及方法
AU2019344801A1 (en) * 2018-09-17 2021-05-20 Board Of Regents, The University Of Texas System Compositions and methods for treating bone injury

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731440A (en) * 1985-02-22 1988-03-15 Monsanto Company Method of somatotropin solubilization using dimethylsulfone and naturation
JPH0759598B2 (ja) * 1986-02-14 1995-06-28 藤沢薬品工業株式会社 ヒトインスリン様成長因子▲ｉ▼の製造法
EP0293785A3 (fr) * 1987-05-29 1990-05-02 Oncogen Limited Partnership Clonage et expression du facteur de croissance transformant simien SS-1
US5061786A (en) * 1989-05-25 1991-10-29 Genentech, Inc. Biologically active polypeptides based on transforming growth factor-β
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5144006A (en) * 1991-06-13 1992-09-01 The Rockefeller University Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides
AU2738392A (en) * 1991-11-11 1993-05-13 Ciba-Geigy Ag Novel hybrid transforming growth factors

Also Published As

Publication number Publication date
NO316926B1 (no) 2004-06-28
IL114701A0 (en) 1995-11-27
TW440566B (en) 2001-06-16
CA2194582A1 (fr) 1996-02-08
AU3109595A (en) 1996-02-22
PT775159E (pt) 2002-04-29
DK0775159T3 (da) 2002-02-11
IL114701A (en) 2005-11-20
NO970325D0 (no) 1997-01-24
KR100432839B1 (ko) 2004-08-30
AU690311B2 (en) 1998-04-23
US6057430A (en) 2000-05-02
EP0775159B1 (fr) 2001-10-31
DE69523605D1 (de) 2001-12-06
JPH11505506A (ja) 1999-05-21
HU222830B1 (hu) 2003-11-28
EP0775159A1 (fr) 1997-05-28
JP3923516B2 (ja) 2007-06-06
WO1996003432A1 (fr) 1996-02-08
NO970325L (no) 1997-03-06
ATE207933T1 (de) 2001-11-15
DE69523605T2 (de) 2002-07-11
FI970229A0 (fi) 1997-01-20
JP2007031453A (ja) 2007-02-08
NZ290373A (en) 1998-04-27
FI970229A (fi) 1997-01-20
HUT76668A (en) 1997-10-28
CA2194582C (fr) 2008-09-02
ES2166401T3 (es) 2002-04-16
ZA956138B (en) 1996-03-07

Similar Documents

Publication Publication Date Title
JP4354980B2 (ja) 生物学的に活性なタンパク質の製造のための新規の方法
KR100203230B1 (ko) 생물학적 활성 이량체 형태의 생장 변환 인자 b 또는 골 형태발생 단백질을 제조하는 방법
JP2007031453A (ja) 生物学的に活性な二量体型タンパク質の製造のための新規の方法
NZ245047A (en) Hybrid transforming growth factor and recombinant dna encoding such a hybrid

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FG Patent granted

Ref document number: 118083

Country of ref document: FI